Evidence map›Paper›PMID 29523823›Full record

Trial reportScientific reports2018

Evaluation of the therapeutic effects of QuickOpt optimization in Chinese patients with chronic heart failure treated by cardiac resynchronization.

Ji Yan, Shu Zhang, Dejia Huang, Xiaolin Xue, Jing Xu, Qianmin Tao, Weize Zhang, Zheng Zhang, Wei Hua, Yanchun Liang and 24 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Echocardiography- versus intracardiac electrocardiogram-based optimization of cardiac resynchronization therapy: A systematic review.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2023
    Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 20 institutions in 1 country.

Ji YanDepartment of Cardiology, Anhui Provincial Hospital, No. 17 Lujiang Road, Hefei, 230001, China.
Shu ZhangCardiac Arrhythmia center, Fuwai Hospital, Chinese Academy of medical Sciences, No. 167 North Lishi Road, Beijing, 100037, China. ZhangShu021617@163.com.
Dejia HuangDepartment of Cardiology, West China Hospital, Sichuan University, No. 37 Guoxue lane, Chengdu, 610041, China. HuangDejia021617@163.com.
Xiaolin XueDepartment of Cardiology, The First Affiliated Hospital of Xi'an Jiaotong University, No. 277 Yanta West Road, Xi'an, 710061, China.
Jing XuDepartment of Cardiology, Tianjin chest hospital, No. 93 Xi'an Road, Tianjin, 300051, China.
Qianmin TaoDepartment of Cardiology, The First Affiliated Hospital, Zhejiang University, No. 79 Qingchun Road, Hangzhou, 310003, China.
Weize ZhangDepartment of Cardiology, The General Hospital of Lanzhou Military, No. 98 Xiaoxihu West Street, Lanzhou, 730050, China.
Zheng ZhangDepartment of Cardiology, The First Hospital of Lanzhou University, No. 1 Donggang West Road, Lanzhou, 730000, China.
Wei HuaCardiac Arrhythmia center, Fuwai Hospital, Chinese Academy of medical Sciences, No. 167 North Lishi Road, Beijing, 100037, China.
Yanchun LiangDepartment of Cardiology, The General Hospital of Shenyang Military, No. 83 Wenhua Road, Shenyang, 110840, China.
Baopeng TangDepartment of Cardiology, The First Affiliated Hospital of Xinjiang Medical University, No. 137 Liyushan South Road, Urumqi, 830054, China.
Wei XuDepartment of Cardiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, 210008, China.
Geng XuDepartment of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, No. 88 Jiefang Road, Hangzhou, 310009, China.
Xuejun RenDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen Road, Beijing, 100029, China.
Jingfeng WangDepartment of Cardiology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, No. 107 Yanjiang West Road, Guangzhou, 510120, China.
Tao GuoDepartment of Cardiology, The First Affiliated Hospital of Kunming Medical University, No. 295 Xichang Road, Kunming, 650032, China.
Shaobin JiaDepartment of Cardiology, General Hospital of Ningxia Medical University, No. 804 Shengli South Street, Yinchuan, 750004, China.
Yugang DongDepartment of Cardiology, The First Affiliated Hospital of Sun Yat-sen University, No. 58 Zhongshan Er Road, Guangzhou, 510080, China.
Hong JiangDepartment of Cardiology, Renmin Hospital of Wuhan University, No. 99 Zhangzhidong Road, Wuhan, 430060, China.
Guosheng FuDepartment of Cardiology, Sir Run Run Shaw Hospital of Medicine, Zhejiang University, No. 3 Qingchun East Road, Hangzhou, 310020, China.
Liguang ZhuDepartment of Cardiology, The First Affiliated Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Nanjing, 530021, China.
Lin ChenDepartment of Cardiology, Fujian Provincial Hospital, No. 134 East Street, Fuzhou, 350001, China.
Fuli TianThe First Department of Cardiology, The 251ST Hospital of PLA, No. 13 Jianguo Road, Zhangjiakou, 075000, China.
Feng LingDepartment of Cardiology, Hangzhou First People's Hospital, No. 261 HuanSha Road, Hangzhou, 310006, China.
Jianmei LiDepartment of Cardiology, The second people's Hospital of Yunnan Province, No. 176 Qingnian Road, Kunming, 650021, China.
Xiaoyong QiDepartment of Cardiology, Hebei General Hospital, No. 348 Heping West Road, Shijiazhuang, 050051, China.
Yinglu HaoDepartment of Cardiology, People's Hospital of Yuxi City, No. 21 Nieer Road, Yuxi, 653100, China.
Yutang WangDepartment of Cardiology, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing, 100853, China.
Liangrong ZhengDepartment of Cardiology, The First Affiliated Hospital, Zhejiang University, No. 79 Qingchun Road, Hangzhou, 310003, China.
Xiaoqun PuDepartment of Cardiology, Xiangya Hospital Central South University, No. 87 xiangya Road, Changsha, 410008, China.
Farong ShenDepartment of Cardiology, Zhejiang Greentown Hospital, No. 409 Gudun Road, Hangzhou, 310000, China.
Guangping LiDepartment of Cardiology, The Second Hospital of Tianjin Medical University, No. 23 Pingjiang Road, Tianjin, 300211, China.
Hui LiDepartment of Cardiology, Daqing Oilfield General Hospital, No. 9 Zhongkang Street, Daqing, 163000, China.
Fang PengDepartment of Cardiology, Shaoxing People's Hospital, No. 568 Zhongxing North Road, Shaoxing, 312000, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNFirst Affiliated Hospital Zhejiang University · CNAnhui Provincial Hospital · CNBeijing Anzhen Hospital · CNCentral South University · CNChinese PLA General Hospital · CNDaqing Oilfield General Hospital · CNFirst Affiliated Hospital of GuangXi Medical University · CNFirst Affiliated Hospital of Kunming Medical University · CNFirst Affiliated Hospital of Xi'an Jiaotong University · CNFujian Provincial Hospital · CNGeneral Hospital of Shenyang Military Region · CNHangzhou First People's Hospital · CNHebei General Hospital · CNKunming Medical University · CNLanzhou Army General Hospital · CNLanzhou University · CNNanjing Drum Tower Hospital · CNNingxia Medical University · CNRenmin Hospital of Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this trial, long-term therapeutic effects and clinical improvements in Chinese chronic heart failure patients optimized by QuickOpt or echocardiography were compared for atrioventricular (AV) and interventricular (VV) delay optimizations after cardiac resynchronization therapy (CRT) with pacing (CRT-P) or with pacing and defibrillator (CRT-D) therapy. One hundred and ninety-six subjects (50%) had dilated cardiomyopathy, 108 (27.6%) had ischemic heart disease and 112 (28.6%) were hypertensive and were randomized into QuickOpt (198) or echocardiographic optimization (control) (194) groups at ≤2-weeks post-implantation. Programmed AV/VV delay was optimized at baseline and at 3 and 6 months. Left ventricular end-systolic volume (LVESV), New York Heart Association (NYHA) class, specific activity scale (SAS), and the six-minute walk tests (6MWT) were evaluated by blinded researchers at 12 months. Of the QuickOpt group, LVESV decreased significantly by 24.7% ± 33.9% compared with baseline, while LVESV of Controls decreased by 25.1% ± 36.1% (P = 0.924). NYHA class, SAS and 6MWT also improved similarly in both groups at 12 months. Mortality in both groups was not significantly different (11.0% vs 7.6%, P = 0.289). However, there was a significant difference in the time required for optimization by QuickOpt compared with echocardiography (3.33 ± 3.11 vs 58.79 ± 27.03 minutes, P < 0.000).

Indexed as

AgedAlgorithmsCardiac Resynchronization TherapyEchocardiographyElectrocardiographyFemaleHeart FailureHumansMaleMiddle Aged

Identifiers

PMID29523823
PMCPMC5844885
OpenAlexW2791216161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.